Contact us

521 Results:

Sort By:

Prolacta Bioscience Provides Update on Latest SARS-CoV-2 Data and Continued Safety of Its Human Milk-Based Nutritional Products

Type: Press Releases

Topic(s): Quality & Safety

Donor Stephanie

Type: Donor Stories

Topic(s): Tiny Treasures

Donor Abbie

Type: Donor Stories

Topic(s): 26 weeker Tiny Treasures

Donor Jade

Type: Donor Stories

Topic(s): Tiny Treasures

Synova Webinar: Human Donor Milk Safety, A Nurse Leadership Call to Action

Type: Events

Topic(s): Feeding Protocols Healthcare Professionals Pasteurization Quality & Safety

CE Webinar: Human Milk: A Source of Life More Than We Imagined

Type: Events

Topic(s): Conferences and Events Healthcare Professionals

Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis

Prolacta Bioscience Fortifiers Reduce Risk of Serious Lung Disease and Hospital Costs Among Premature Infants, Compared to Cow Milk-Based Fortifiers

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD)

Donor Lindsey

Type:

Topic(s):

Not finding the reference you’re looking for?

Email us at info@prolacta.com